BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 17295095)

  • 21. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation of NK cell function and their modulation in different malignancies.
    Konjevic G; Jurisic V; Jovic V; Vuletic A; Mirjacic Martinovic K; Radenkovic S; Spuzic I
    Immunol Res; 2012 Apr; 52(1-2):139-56. PubMed ID: 22442005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response of murine and normal human skin to injection of allogeneic blood-derived psoriatic immunocytes: detection of T cells expressing receptors typically present on natural killer cells, including CD94, CD158, and CD161.
    Nickoloff BJ; Wrone-Smith T; Bonish B; Porcelli SA
    Arch Dermatol; 1999 May; 135(5):546-52. PubMed ID: 10328195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia.
    Morice WG; Kurtin PJ; Leibson PJ; Tefferi A; Hanson CA
    Br J Haematol; 2003 Mar; 120(6):1026-36. PubMed ID: 12648073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased expression of pSTAT, IRF-1 and DAP10 signalling molecules in peripheral blood lymphocytes of patients with metastatic melanoma.
    Mirjačić Martinović K; Srdić-Rajić T; Babović N; Džodić R; Jurišić V; Konjević G
    J Clin Pathol; 2016 Apr; 69(4):300-6. PubMed ID: 26442832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptide: MHC-based DNA vaccination strategy to activate natural killer cells by targeting killer cell immunoglobulin-like receptors.
    Rettman P; Blunt MD; Fulton RJ; Vallejo AF; Bastidas-Legarda LY; España-Serrano L; Polak ME; Al-Shamkhani A; Retiere C; Khakoo SI
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34016721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Telomere length in human natural killer cell subsets.
    Ouyang Q; Baerlocher G; Vulto I; Lansdorp PM
    Ann N Y Acad Sci; 2007 Jun; 1106():240-52. PubMed ID: 17303822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
    Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
    Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuated in vitro effects of IFN-α, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients.
    Mirjačić Martinović KM; Vuletić AM; Lj Babović N; Džodić RR; Konjević GM; Jurišić VB
    Cytokine; 2017 Aug; 96():30-40. PubMed ID: 28282548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trophoblast cell line resistance to NK lysis mainly involves an HLA class I-independent mechanism.
    Avril T; Jarousseau AC; Watier H; Boucraut J; Le Bouteiller P; Bardos P; Thibault G
    J Immunol; 1999 May; 162(10):5902-9. PubMed ID: 10229826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.
    Jacobs R; Hintzen G; Kemper A; Beul K; Kempf S; Behrens G; Sykora KW; Schmidt RE
    Eur J Immunol; 2001 Oct; 31(10):3121-7. PubMed ID: 11592089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4+,CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems.
    Warrington KJ; Takemura S; Goronzy JJ; Weyand CM
    Arthritis Rheum; 2001 Jan; 44(1):13-20. PubMed ID: 11212151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.
    Garcia-Iglesias T; Del Toro-Arreola A; Albarran-Somoza B; Del Toro-Arreola S; Sanchez-Hernandez PE; Ramirez-Dueñas MG; Balderas-Peña LM; Bravo-Cuellar A; Ortiz-Lazareno PC; Daneri-Navarro A
    BMC Cancer; 2009 Jun; 9():186. PubMed ID: 19531227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.
    Markel G; Seidman R; Besser MJ; Zabari N; Ortenberg R; Shapira R; Treves AJ; Loewenthal R; Orenstein A; Nagler A; Schachter J
    PLoS One; 2009; 4(5):e5597. PubMed ID: 19440333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of interleukin-15 on the expression of killer-cell immunoglobulin-like receptors on peripheral natural killer cells in human.
    Kogure T; Mantani N; Goto H; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2002 Aug; 11(4):219-24. PubMed ID: 12396473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-4-induced natural killer cell antitumor activity in metastatic melanoma patients.
    Vuletić AM; Konjević GM; Larsen AK; Babović NL; Jurišić VB; Krivokuća A; Mirjačić Martinović KM
    Eur Cytokine Netw; 2020 Dec; ():. PubMed ID: 33270021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-18 synergism with interleukin-2 in cytotoxicity and NKG2D expression of human natural killer cells.
    Qi YY; Lu C; Ju Y; Wang ZE; Li YT; Shen YJ; Lu ZM
    Asian Pac J Cancer Prev; 2014; 15(18):7857-61. PubMed ID: 25292077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The negative regulatory effect of IFN-gamma on cognitive function of human natural killer cells].
    Zhang C; Tian ZG; Zhang J; Feng JB; Zhang JH; Xu XQ
    Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):324-7. PubMed ID: 15312339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.